Related Experiment Video
Updated: Jan 10, 2026

03:23
Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
Published on: May 10, 2024
1.3K
Application of artificial intelligence in eosinophilic esophagitis
Xiaoming Xu1, Hualei Chen1, Yun Chen2
1Department of Gastroenterology, Jining No. 1 People's Hospital, Jining, China.
Frontiers in Immunology
|November 26, 2025
Summary
Artificial intelligence (AI) shows promise in managing eosinophilic esophagitis (EoE). AI improves diagnosis, treatment prediction, and personalized care, though challenges in explainability and validation remain.
Area of Science:
- Gastroenterology
- Medical Informatics
Background:
- Eosinophilic esophagitis (EoE) is a chronic immune-mediated esophageal disease.
- Current EoE management relies on endoscopic and histopathological assessments, which can have inter-observer variability.
Purpose of the Study:
- To review the potential applications and challenges of artificial intelligence (AI) in eosinophilic esophagitis (EoE) management.
- To highlight AI's role in enhancing diagnostic accuracy, treatment prediction, and personalized medicine approaches for EoE.
Main Methods:
- Literature review of AI applications in EoE.
- Analysis of AI's performance in endoscopic and histopathological analysis.
- Discussion of AI's potential in identifying biomarkers and predicting treatment response.
Main Results:
- AI demonstrates comparable or superior performance to non-experts in diagnostic tasks.
- AI aids in standardizing EoE assessments (e.g., EREFS, EoEHSS).
- AI facilitates precision medicine by identifying molecular phenotypes and predicting treatment outcomes.
Conclusions:
- AI offers significant potential to improve EoE diagnosis, management, and treatment personalization.
- Addressing challenges like explainability (XAI), validation in diverse cohorts, and regulatory approval is crucial for AI integration.
- Future research should focus on pediatric populations, non-invasive monitoring, and integrated AI platforms for proactive EoE care.
Related Concept Videos
Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K

